Journals / MN Kardiyoloji / 2008 / Cilt: 15 - Sayı: 1

Relation of admission mean platelet volume with reperfusion in acutest segment elevation myocardial infarction patients treated with fibrinolytic therapy

Fibrinolitik tedavi uygulanan akut miyokard infarktüsü hastalarında hastaneye başvuru anındaki ortalama trombosit hacmi ile reperfüzyon başarısı arasındaki ilişki

Pages
25–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Platelets, apart from having a pivotal role in pathogenesis of acute coronary syndromes, may have an adverse effect on the reperfusion response to fibrinolytic treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Platelet size measured as mean platelet volume (MPV) correlates with their reactivity.
📊
Key Findings & Data:Material and Methods: Blood samples for MPV were obtained on admission in 179 acute STEMI patients who were subsequently administered fibrinolytic therapy.
💡
Conclusion & Impact:Platelets, apart from having a pivotal role in pathogenesis of acute coronary syndromes, may have an adverse effect on the reperfusion response to fibrinolytic treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Akut hastalık · Elektrokardiyografi · Fibrinolitik ajanlar

Abstract

Aim: Platelet size measured as mean platelet volume (MPV) correlates with their reactivity. The aim of this study was to evaluate a possible relationship of admission MPV with reperfusion in acute ST segment elevation myocardial infarction (STEMI) patients treated wih fibrinolytic therapy. Material and Methods: Blood samples for MPV were obtained on admission in 179 acute STEMI patients who were subsequently administered fibrinolytic therapy. Standard 12 lead ECGs were taken on admission and at 90 minutes after completion of fibrinolytic treatment. Based on 90th minute ST resolution (STR) ratio patients were divided into reperfusion (&#8805;70% STR) and impaired reperfusion (<70% STR) groups. Results: In 77 (44%) patients electrocardiographic reperfusion was observed. Reperfusion group patients had sinificantly longer pain to needle interval when compared to the patients in impaired reperfusion group (3.9±2.3 vs 5.2±3.1h, p=0.012). Anterior MI was more frequent in impaired reperusion group patients (p=0.008). The patients in impaired reperfuson group had significantly higher MPV compared to patients in reperfusion group (8.8±0.9 vs 8.0±0.7fL, p<0.001). In regression analysis admission MPV was found to be an independent predictor of impaired reperfusion. Conclusion: The patients who had higher admission MPV were found to be under higher risk of impaired reperfusion in our study group. Platelets, apart from having a pivotal role in pathogenesis of acute coronary syndromes, may have an adverse effect on the reperfusion response to fibrinolytic treatment.

Özet

Amaç: Ortalama trombosit hacmi (OTH) trombosit aktivitesinin bir göstergesi olarak kabul edilmektedir. Bu çalışma, akut ST yükseklikli miyokard infarktüsü nedeni ile fibrinolitik tedavi uygulanmış hastalarda, hastaneye başvuru anında ölçülen OTH ile reperfüzyon başarısı arasında bir ilişki olup olmadığını araştırmak amacıyla yapılmıştır. Gereç ve Yöntem: Akutmiyokard infarktüslü, fibrinolitik tedavi uygulanan toplam179 hastadan, hastaneye kabulde OTH için kan örneklemesi alındı. Tüm hastalardan fibrinolitik tedavi başlanmadan ve tedavinin bitişinden sonra 90. dakikada standart 12 derivasyonlu EKG çekildi. Reperfüzyon 90. dakikadaki ST segment rezolüsyonu (STR) oranına göre değerlendirildi. Hastalar reperfüze olan (≥%70 STR) ve olmayan (<%70 STR) olarak iki alt gruba bölünerek istatistiksel analiz gerçekleştirildi. Bulgular: Çalışmaya alınan hastaların 77 (%44)’sinde elektrokardiyografik olarak başarılı reperfüzyon sağlandığı saptandı. Bu hastalar, reperfüze olmayan hastalara nazaran hastaneye ağrı başlangıcından itibaren daha erken başvurmuştu (3.9±2.3 saate karşın 5.2±3.1 saat, p=0.012). Ön duvar miyokard infarktüsü reperfüze olmayan grupta anlamlı oranda daha sıktı (p=0.008). İncelenen hematolojik parametreler açısından iki grup arasında yalnızca OTH açısından anlamlı fark saptandı. Reperfüzyonun başarısız olduğu gruptaki hastalar, reperfüze gruptaki hastalara nazaran daha yüksek OTH’ne sahiptiler (8.8±0.9’ye karşın 8.0±0.7fL, p<0.001). Regresyon analizinde OTH reperfüzyonun bağımsız öngördürücüsü olarak saptanmıştır. Sonuç: Başvuruda daha yüksek OTH’ne sahip hastalar fibrinolitik tedavi sonrasında başarısız reperfüzyon açısından daha riskli bir grubu oluşturmaktadırlar. Akut koroner sendromların patogenezinde merkezi bir yer tutan trombositler, fibrinolitik tedaviye reperfüzyon cevabının oluşmasında da belirleyici bir role sahip olabilir.

🔖

Cite This Article

MADEN, O., KAÇMAZ, F., ÇELEBİ, S. A., ÜREYEN, Ç. M., SELÇUK, M. T., ÖZEKE, Ö., ERBAY, A. R., ULUSOY, F. V., İLKAY, E. (2008). Relation of admission mean platelet volume with reperfusion in acutest segment elevation myocardial infarction patients treated with fibrinolytic therapy. MN Kardiyoloji, Cilt: 15 - Sayı: 1, 25–31. https://ajindex.com/articles/297488

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Menon V, Harrington RA, Hochman JS, Cannon CP, Goodman SD, Wilcox RG, et al. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004
  2. 549S-75S. 2.Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists1 (FTT) Collaborative Group. Lancet 1994
  3. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993
  4. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation 1990
  5. Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Circulation. 1998
  6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993
  7. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995
  8. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. Blood 1984
  9. 5 9.Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest 1969
  10. Schroder R, Dissmann R, Bruggemann T, Wegscheider K, Linderer T, Tebbe U, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994
  11. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992
  12. Greaves K, Dixon SR, Fejka M, O'Neill WW, Redwood SR, Marber MS, et a. Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction. Heart. 2003
  13. Muzik 0, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. V